| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:22:36 UTC |
|---|
| Updated at | 2022-04-27 22:22:37 UTC |
|---|
| NP-MRD ID | NP0050909 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Tabersonine |
|---|
| Description | Tabersonine belongs to the class of organic compounds known as plumeran-type alkaloids. These are alkaloids with a structure based on the plumeran skeleton. Plumeran is a pentacyclic compound that consists of a pyrrolidine ring shed to the quinoline moiety of pyrido[3,2-c]carbazole ring system. Tabersonine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Tabersonine is found in Alstonia yunnanensis, Amsonia angustifolia, Amsonia elliptica, Amsonia illustris, Amsonia tabernaemontana, Amsonia tomentosa, Apis cerana, Catharanthus roseus , Catharanthus trichophyllus, Tabernaemontana divaricata, Ervatamia divaricata Gouyahua, Melodinus fusiformis, Melodinus suaveolens, Rauvolfia serpentina, Tabernaemontana grandiflora, Tabernaemontana alternifolia, Tabernaemontana catharinensis, Tabernaemontana citrifolia, Tabernaemontana cymosa, Tabernaemontana litoralis, Vinca herbacea Waldst.et Kit. and Voacanga africana . Tabersonine was first documented in 2021 (PMID: 34680551). Based on a literature review a small amount of articles have been published on tabersonine (PMID: 35323487) (PMID: 34531512) (PMID: 34459997) (PMID: 34302444). |
|---|
| Structure | CC[C@@]12CC(C(=O)OC)=C3NC4=C(C=CC=C4)[C@@]33CCN(CC=C1)[C@@H]23 InChI=1S/C21H24N2O2/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2/h4-9,19,22H,3,10-13H2,1-2H3/t19-,20-,21-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (5alpha,12beta,19alpha)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylic acid, methyl ester | ChEBI | | Methyl (5alpha,12beta,19alpha)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate | ChEBI | | Tabersonin | ChEBI | | (5a,12b,19a)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylate, methyl ester | Generator | | (5a,12b,19a)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylic acid, methyl ester | Generator | | (5alpha,12beta,19alpha)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylate, methyl ester | Generator | | (5Α,12β,19α)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate, methyl ester | Generator | | (5Α,12β,19α)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylic acid, methyl ester | Generator | | Methyl (5a,12b,19a)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate | Generator | | Methyl (5a,12b,19a)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylic acid | Generator | | Methyl (5alpha,12beta,19alpha)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylic acid | Generator | | Methyl (5α,12β,19α)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate | Generator | | Methyl (5α,12β,19α)-2,3,6,7-tetradehydroaspidospermidine-3-carboxylic acid | Generator | | Tabersonine monoacetate | MeSH |
|
|---|
| Chemical Formula | C21H24N2O2 |
|---|
| Average Mass | 336.4350 Da |
|---|
| Monoisotopic Mass | 336.18378 Da |
|---|
| IUPAC Name | methyl (1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2(7),3,5,9,13-pentaene-10-carboxylate |
|---|
| Traditional Name | methyl (1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2(7),3,5,9,13-pentaene-10-carboxylate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@@]12CC(C(=O)OC)=C3NC4=C(C=CC=C4)[C@@]33CCN(CC=C1)[C@@H]23 |
|---|
| InChI Identifier | InChI=1S/C21H24N2O2/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2/h4-9,19,22H,3,10-13H2,1-2H3/t19-,20-,21-/m0/s1 |
|---|
| InChI Key | FNGGIPWAZSFKCN-ACRUOGEOSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as plumeran-type alkaloids. These are alkaloids with a structure based on the plumeran skeleton. Plumeran is a pentacyclic compound that consists of a pyrrolidine ring shed to the quinoline moiety of pyrido[3,2-c]carbazole ring system. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Plumeran-type alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Plumeran-type alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Plumeran-type alkaloid
- Carbazole
- Indole or derivatives
- Dihydroindole
- Secondary aliphatic/aromatic amine
- Aralkylamine
- N-alkylpyrrolidine
- Benzenoid
- Pyrrolidine
- Methyl ester
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Vinylogous amide
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Secondary amine
- Enamine
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic oxide
- Amine
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Tang W, Liu X, He Y, Yang F: Enhancement of Vindoline and Catharanthine Accumulation, Antioxidant Enzymes Activities, and Gene Expression Levels in Catharanthus roseus Leaves by Chitooligosaccharides Elicitation. Mar Drugs. 2022 Mar 3;20(3). pii: md20030188. doi: 10.3390/md20030188. [PubMed:35323487 ]
- Shekunov EV, Efimova SS, Yudintceva NM, Muryleva AA, Zarubaev VV, Slita AV, Ostroumova OS: Plant Alkaloids Inhibit Membrane Fusion Mediated by Calcium and Fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 Fusion Peptides. Biomedicines. 2021 Oct 10;9(10). pii: biomedicines9101434. doi: 10.3390/biomedicines9101434. [PubMed:34680551 ]
- Liu T, Huang Y, Jiang L, Dong C, Gou Y, Lian J: Efficient production of vindoline from tabersonine by metabolically engineered Saccharomyces cerevisiae. Commun Biol. 2021 Sep 16;4(1):1089. doi: 10.1038/s42003-021-02617-w. [PubMed:34531512 ]
- Mall M, Shanker K, Samad A, Kalra A, Sundaresan V, Shukla AK: Stress responsiveness of vindoline accumulation in Catharanthus roseus leaves is mediated through co-expression of allene oxide cyclase with pathway genes. Protoplasma. 2022 May;259(3):755-773. doi: 10.1007/s00709-021-01701-6. Epub 2021 Aug 30. [PubMed:34459997 ]
- Kulagina N, Guirimand G, Melin C, Lemos-Cruz P, Carqueijeiro I, De Craene JO, Oudin A, Heredia V, Koudounas K, Unlubayir M, Lanoue A, Imbault N, St-Pierre B, Papon N, Clastre M, Giglioli-Guivarc'h N, Marc J, Besseau S, Courdavault V: Enhanced bioproduction of anticancer precursor vindoline by yeast cell factories. Microb Biotechnol. 2021 Nov;14(6):2693-2699. doi: 10.1111/1751-7915.13898. Epub 2021 Jul 24. [PubMed:34302444 ]
|
|---|